Curcumin Withdrawn Phase 2 Trials for Cutaneous T-Cell Lymphoma (CTCL) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00969085Trial of Curcumin in Cutaneous T-cell Lymphoma Patients